Provided by Tiger Trade Technology Pte. Ltd.

HORIZON KINETICS MEDICAL ETF

34.66
-0.1046-0.30%
Post-market: 34.660.00000.00%16:10 EDT
Volume:188
Turnover:7K
Market Cap:16.29M
PE:- -
High:34.66
Open:34.76
Low:34.66
Close:34.76
52wk High:37.90
52wk Low:30.79
Shares:469.95K
Float Shares:469.95K
Volume Ratio:0.58
T/O Rate:0.04%
Dividend:0.41
Dividend Rate:1.18%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

AbbVie Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
19 mins ago

Abbvie-from Jan 1, 2027, Covered Entities to Submit Claims to GET 340B Pricing Through Beacon on 340B-Eligible Dispenses of Imbruvica, Linzess,Vraylar

THOMSON REUTERS
·
52 mins ago

Abbvie - Approved to Participate in Federal 340B Rebate Model Pilot Program

THOMSON REUTERS
·
52 mins ago

Former Eli Lilly Exec Sells Wyoming Estate for Close to $39.5 Million

Dow Jones
·
1 hour ago

Why Medtronic's $4 Billion MiniMed Exchange Offer is Losing Its Allure

Dow Jones
·
1 hour ago

Eli Lilly announces FDA approves additional indication for Jaypirca

TIPRANKS
·
1 hour ago

Lilly Says FDA Approves Expanded First-Line Cll/sll Use for Jaypirca

Reuters
·
1 hour ago

Lilly's Jaypirca (Pirtobrutinib), the First-and-Only Approved Non-Covalent Btk Inhibitor, Receives Expanded Indication from U.S. FDA for Certain Patients with Previously Untreated Cll/Sll

THOMSON REUTERS
·
1 hour ago

Dow Jones Top Company Headlines at 3 PM ET: FAA Says 737 MAX Software Glitch Doesn't Pose Safety Issue | Tesla ...

Dow Jones
·
1 hour ago

Legend Biotech Faces Pressure From Rivals Ahead of Key FDA Decision, UBS Says

MT Newswires Live
·
3 hours ago

AbbVie’s Venetoclax AML Study in Greece: What the Latest Update Means for Investors

TIPRANKS
·
4 hours ago

Novartis AG Falls Friday, Underperforms Market

Dow Jones
·
4 hours ago

Dow Jones Top Company Headlines at 11 am ET: Tesla Sales Slump in Third Quarter | David ...

Dow Jones
·
Yesterday

Candel Therapeutics to Present at the SITC 2026 Annual Meeting

GlobeNewswire
·
Yesterday

Correction: Top Midday Decliners

MT Newswires Live
·
Yesterday

Press Release: Celcuity Appoints David Gryska to Its Board of Directors

Dow Jones
·
Yesterday

Verastem announces data from analysis of Phase 2 RAMP 201 trial

TIPRANKS
·
Yesterday

Novartis to License Drug from China's Abogen in up to $7.8 Billion Deal

Dow Jones
·
Yesterday

Johnson & Johnson announces two-year data from Phase 3 ICONIC-TOTAL study

TIPRANKS
·
Yesterday

Johnson & Johnson Says Icotyde Sustains Psoriasis Skin Clearance Through 2 Years in Phase 3 Iconic-TOTAL Study

Reuters
·
Yesterday